PRDM9 and cancer: Epigenetic regulators play important roles in tumor evolution, among which histone methyltransferases (HMTs) have increasingly become the appealing therapeutic targets for cancer disease interventions because they are frequently dysregulated in a spectrum of human cancers [1].